濱江集團(002244.SZ):競得2宗地塊
格隆匯7月27日丨濱江集團(002244.SZ)公佈,2021年7月26日,在浙江省土地使用權網上交易系統舉辦的掛牌出讓活動中,公司全資子公司杭州繽斐企業管理有限公司和杭州繽滄企業管理有限公司分別競得淳政儲出【2021】9號和淳政儲出【2021】10號地塊的國有建設用地使用權。

杭州繽斐企業管理有限公司和杭州繽滄企業管理有限公司已獲取《競得入選人通知書》,將根據有關規定分別與淳安縣規劃和自然資源局簽署《成交確認書》。
公司目前擁有上述競拍地塊100%的權益。鑑於未來公司可能就項目引入合作者,公司在上述項目中所佔權益比例可能發生變化,上述比例僅供投資者作階段性參考。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.